YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[US 100 dollar bill folded into an up arrow on wooden table. Illustration of the concept of inflation, profit, earning and investment] Biotech stocks have reached their highest level since the height of the pandemic after Moderna (MRNA [ht…
[Bubble] Petrovich9 The top 10 stocks in the U.S. now represent approximately 45% of total market capitalization, a level of concentration that has broken traditional market trend lines and left investors struggling to determine whether th…
[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American…
Shareholders of Hartford Insurance Group Inc (Symbol: HIG) looking to boost their income beyond the stock's 1.7% annualized dividend yield can sell the March 2026 covered call at the $130 strike and collect the premium based on the $4.70 b…
* ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB [https://seekingalpha.com/symbol/BIB]) - $0.1706. * Payable Jul 01; for shareholders of record Jun 25; ex-div Jun 25. MORE ON PROSHARES ULTRA NASDAQ BIOTECHNOLOGY ETF * Seeking Alpha’s Qua…
Some of the market’s favorite biotech stocks have created immense wealth, as in the recent weight-loss drug stock boom. On May 26, Viking Therapeutics (NASDAQ:VKTX) was trading around $20.25. Today, after hitting a high of $99.41, it trade…
Some of the hottest biotech stocks are safe and recession-proof. After all, we can’t stop people from aging – at least, not yet. We can’t stop people from seeking treatments for a myriad of issues. Plus, there’s growing demand for innovati…
OSLO, Norway, Jan. 31, 2022 /PRNewswire/ -- Aker Carbon Capture, Altera Infrastructure and Höegh LNG have entered a non-exclusive collaboration to explore a full value chain offering for carbon capture, utilization, and storage (CCUS). "St…
Read a comparison of BIB and LABU and a description of the characteristics and historical performance of these leveraged biotech ETFs.
Marc Lichtenfeld, an expert in biotech and income stocks, notes that a lot of Wall Street money moves into companies that issue positive Phase 2 clinical trial data.
Nasdaq Stock Exchange President Nelson Griggs joins Yahoo Finance’s Seana Smith to discuss market operations amid the coronavirus and the outlook on IPOs. Video Transcript SEANA SMITH: Welcome back to Yahoo Finance's live market coverage.…